Operator Welcome to the Lannett Company's Fiscal 2021 Third Quarter Financial Results Conference Call. My name is Hilda and I will be your operator for today. Later, we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over to Mr. Robert Jaffe, Investor Relations for Lannett. Mr. Jaffe, you may begin. Robert Jaffe -- Investor Relations for Lannett Good afternoon, everyone, and thank you for joining us today to discuss Lannett Company's fiscal 2021 third quarter financial results. On the call today are Tim Crew, Chief Executive Officer; John Kozlowski, the company's Chief Financial Officer, Maureen Cavanaugh, our Chief Commercial Operations Officer and Steve Lehrer, who leads our insulin biosimilar initiatives. This call is being broadcast live at www.lannett.com. A playback will be available for at least three months on Lannett's website. I would like to make the cautionary statement and remind everyone that all of the information discussed on today's call is covered under the Safe Harbor provisions of the Litigation Reform Act. The Company's discussion will include forward-looking information reflecting management's current forecast of certain aspects of the Company's future and actual results could differ materially from those stated or implied.